Project Grant K99AG087723
Award Date
9/13/24
Completion Date
8/31/26
Dollars Obligated
$123K
Federal Agency
National Institute on Aging
Federal Grant Program
93.866
Assistance Type
Project Grant
Place of Performance
California, USA
Similar Awards
This $659,916 Project Grant award from the National Institute on Aging (CFDA 93.866 - Aging Research) supports research to test the ability of diets with reduced levels of specific amino acids (isoleucine, valine, or histidine) to reverse diet-induced obesity and insulin resistance. The primary objectives are to determine the optimal degree of amino acid restriction to promote metabolic health in animal models, and to evaluate the efficacy of an optimized amino acid-restricted diet in...
This $101,925 Project Grant award was provided by the National Institute on Aging (NIA) under the Aging Research federal grant program (CFDA 93.866) to investigate the role of the propionate metabolism pathway in the aging process. The 2-year project aims to: Continue studying the impact of methylmalonic acid (MMA), a metabolite in the propionate pathway, on cell senescence and aging-associated pulmonary fibrosis. Characterize a novel function of propionyl-CoA (P-CoA), another pathway...
The National Institutes of Health Office of the Director awarded $2,907,000 under the Trans-NIH Research Support program to the Regents of the University of California, San Francisco for a project grant titled "Discovering Mechanisms of Tissue-Resident Immune Aging." The grant will fund research from September 2022 through August 2025 to study the mechanisms driving dysregulation of the aging adipose tissue-resident immune compartment. Specifically, the researchers will use inducible...
The National Institute on Aging (NIA), under the Aging Research federal grant program (CFDA 93.866), awarded a 5-year, $753,728 Project Grant (R01AG085793) to the University of Alabama at Birmingham (UAB) to investigate the role of ceramide signaling in regulating healthspan and lifespan in mouse models. The study aims to determine the association between growth hormone deficiency, altered lipid profiles, and longevity, with a focus on the implications of ceramides in aging-related processes...
This Project Grant award from the National Institute on Aging's (NIA) Aging Research Federal Grant Program (CFDA 93.866) provides $1,394,250 to the Icahn School of Medicine at Mount Sinai to study the molecular mechanisms underlying pathological aging of the human brain and adipose tissue, as well as their inter-organ communication. The project aims to investigate the heterogeneity of human aging and identify the common pathological aging mechanisms shared between the brain (e.g., hippocampus,...
The National Institutes of Health's National Institute on Aging awarded a $7,432,562 project grant to the Regents of the University of California, San Francisco on September 15, 2022 under the Aging Research program (CFDA 93.866). The grant will support research to elucidate the roles of Alzheimer's disease risk genes and variants in gene expression and AD-related phenotypes through 2025. Specifically, the University of California, San Francisco will use CRISPR and single-cell RNA sequencing...
This Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) provides $2,496,057.49 to the University of Arizona to investigate the role of hepatic glucagon receptor signaling in healthspan and aging. The research aims to study the impact of genetic and pharmacological manipulation of glucagon receptor signaling on normal aging, obesity-accelerated aging, and the effects of calorie restriction. This work seeks to identify glucagon receptor...
The National Institute on Aging (NIA) awarded a $137,895 Project Grant under the Aging Research federal grant program (CFDA 93.866) to the University of California, Berkeley (UC Berkeley) with a project period from December 3, 2024 to July 31, 2027. The grant will fund a study to investigate how brain network connectivity is associated with Alzheimer's disease (AD) risk, longitudinal pathology accumulation, and aging. Specifically, the project will use positron emission tomography (PET)...
This $3,841,367 Project Grant award from the National Institute on Aging (NIA) under the Aging Research program (CFDA 93.866) supports research to better understand the role of the TBK1 protein kinase and associated autophagy pathways in frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS). The University of California, San Francisco (UCSF) will use advanced stem cell models and proteomics to: 1) identify novel TBK1 substrates and characterize the effects of TBK1 loss on...
The National Institute on Aging (NIA) awarded a $4,276,054 Project Grant under the Aging Research federal grant program (CFDA 93.866) to The Regents of the University of California, San Francisco (UCSF) on September 1, 2024. The project aims to develop mathematical models to quantitatively test and validate hypotheses regarding the selective vulnerability of genes, cells, and neural networks in mouse models of Alzheimer's disease (AD) tauopathy. The research will leverage two enabling...